Tokyo, Japan

Shigeru Kurata

This inventor holds 1 USPTO granted patent. Top assignee: Teikoku Hormone Mfg. Co., Ltd.. Active years: 1981.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shigeru Kurata: Innovator in Antiulcer Agents

Introduction

Shigeru Kurata is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiulcer agents. His innovative work has led to the creation of a unique class of compounds that hold promise for treating ulcers.

Latest Patents

Shigeru Kurata holds a patent for "Antiulcer phenoxypropylamine derivatives." This patent describes phenoxypropylamine derivatives characterized by a specific general formula. The compounds include various substituents that enhance their medicinal properties, particularly as antiulcer agents. The patent outlines the production process and medicinal uses of these derivatives, emphasizing their potential effectiveness in treating ulcers.

Career Highlights

Shigeru Kurata is associated with Teikoku Hormone Mfg. Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical applications. His work has contributed to the company's reputation as a leader in hormone-related products and innovative medicinal solutions.

Collaborations

Throughout his career, Shigeru Kurata has collaborated with esteemed colleagues, including Kenyu Shibata and Toshihisa Itaya. These collaborations have fostered a productive research environment, leading to advancements in their respective fields.

Conclusion

Shigeru Kurata's contributions to the development of antiulcer agents highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the pharmaceutical industry and offers hope for effective treatments for ulcer-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…